Shopping Cart 0
Cart Subtotal
USD 0

Germany Neuromodulation Devices Market Outlook to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Germany Neuromodulation Devices Market Outlook to 2025

Summary

GlobalData's new report, Germany Neuromodulation Devices Market Outlook to 2025, provides key market data on the Germany Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Neuromodulation Devices market.

- Global corporate-level profiles of key companies operating within the Germany Neuromodulation Devices market.

- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Neuromodulation Devices Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Neuromodulation Devices Market, Germany 7

3.1 Neuromodulation Devices Market, Germany, Revenue (USD m), 2015-2025 7

3.2 Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 10

3.3 Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2025 13

3.4 Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), 2017 15

3.5 Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), 2017 16

4 Overview of Key Companies in Germany, Neuromodulation Devices Market 18

4.1 Medtronic Plc 18

4.1.1 Company Overview 18

4.2 Boston Scientific Corp 18

4.2.1 Company Overview 18

4.3 Nevro Corp 18

4.3.1 Company Overview 18

4.4 LivaNova PLC 18

4.4.1 Company Overview 18

4.5 Abbott Laboratories 19

4.5.1 Company Overview 19

5 Neuromodulation Devices Market Pipeline Products 20

6 Recent Developments 24

6.1 Corporate Communications 24

6.1.1 Jun 13, 2018: Ottobock Appoints Philipp Schulte-Noelle As CFO 24

6.1.2 May 03, 2018: Sarik Weber named Chief Digital Officer of Ottobock 24

6.1.3 Jan 25, 2018: Otto Bock HealthCare: Arne Jorn joins medtech manufacturer 24

6.2 Financial Announcements 25

6.2.1 Jul 03, 2018: Carl Zeiss Meditec increases revenue by around 7% in first nine months 2017/18 and adjusts revenue outlook 25

6.2.2 May 15, 2018: Carl Zeiss Meditec increased revenue in the first six months of 2017/18 by 4.5 percent 25

6.2.3 Feb 12, 2018: Carl Zeiss Meditec Starts New Fiscal Year 2017/18 With Solid Revenue Growth 26

6.2.4 Dec 08, 2017: Carl Zeiss Meditec grows by 9% in fiscal year 2016/17 27

6.3 Government and Public Interest 28

6.3.1 Feb 09, 2018: Deep transcranial magnetic stimulation reduces fatigue in MS patients 28

6.4 Other Significant Developments 28

6.4.1 Jan 18, 2018: Wyss Center announces collaboration with CorTec 28

6.5 Product News 29

6.5.1 Jun 05, 2018: Effects of transcranial magnetic stimulation on the brain 29

7 Appendix 31

7.1 Research Methodology 32

7.1.1 Coverage 32

7.1.2 Secondary Research 32

7.1.3 Primary Research 33

7.1.4 Market Modeling and Forecasting 34

7.1.5 Company Share Analysis 35

7.1.6 Distribution Share Analysis 36

7.1.7 Benchmarking 36

7.2 GlobalData Consulting 36

7.3 Contact Us 37

7.4 Disclaimer 37


List Of Figure

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2025 7

Figure 2: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 10

Figure 3: Neuromodulation Devices Market, Germany, Company Share (%) 2017 16


List Of Table

1.1 List of Tables

Table 1: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2020 8

Table 2: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2021-2025 9

Table 3: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2020 11

Table 4: Neuromodulation Devices Market, Germany, Volume (Units), 2021-2025 12

Table 5: Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2020 13

Table 6: Neuromodulation Devices Market, Germany, Average Price (USD ), 2021-2025 14

Table 7: Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), USD Constant, 2017 15

Table 8: Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), USD Constant, 2017 17

Table 9: Neuromodulation Devices Market Pipeline Products 20

Table 10: Total Number of Primary Research Participants, Neurology Devices Market, by Country 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Neurology Devices, Hydrocephalus shunts, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Natus Medical Incorporated, Stryker Corp, Nevro Corp, Cerenovus, Terumo Corp, LivaNova PLC , Nihon Kohden Corp, Penumbra Inc, Integra LifeSciences Corp, B. Braun Melsungen AG, Accuray Inc, Elekta AB


Companies

Medtronic Plc

Boston Scientific Corp

Nevro Corp

LivaNova PLC

Abbott Laboratories

Germany Neuromodulation Devices Market Outlook to 2025

Summary

GlobalData's new report, Germany Neuromodulation Devices Market Outlook to 2025, provides key market data on the Germany Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Neuromodulation Devices market.

- Global corporate-level profiles of key companies operating within the Germany Neuromodulation Devices market.

- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Neuromodulation Devices Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Neuromodulation Devices Market, Germany 7

3.1 Neuromodulation Devices Market, Germany, Revenue (USD m), 2015-2025 7

3.2 Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 10

3.3 Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2025 13

3.4 Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), 2017 15

3.5 Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), 2017 16

4 Overview of Key Companies in Germany, Neuromodulation Devices Market 18

4.1 Medtronic Plc 18

4.1.1 Company Overview 18

4.2 Boston Scientific Corp 18

4.2.1 Company Overview 18

4.3 Nevro Corp 18

4.3.1 Company Overview 18

4.4 LivaNova PLC 18

4.4.1 Company Overview 18

4.5 Abbott Laboratories 19

4.5.1 Company Overview 19

5 Neuromodulation Devices Market Pipeline Products 20

6 Recent Developments 24

6.1 Corporate Communications 24

6.1.1 Jun 13, 2018: Ottobock Appoints Philipp Schulte-Noelle As CFO 24

6.1.2 May 03, 2018: Sarik Weber named Chief Digital Officer of Ottobock 24

6.1.3 Jan 25, 2018: Otto Bock HealthCare: Arne Jorn joins medtech manufacturer 24

6.2 Financial Announcements 25

6.2.1 Jul 03, 2018: Carl Zeiss Meditec increases revenue by around 7% in first nine months 2017/18 and adjusts revenue outlook 25

6.2.2 May 15, 2018: Carl Zeiss Meditec increased revenue in the first six months of 2017/18 by 4.5 percent 25

6.2.3 Feb 12, 2018: Carl Zeiss Meditec Starts New Fiscal Year 2017/18 With Solid Revenue Growth 26

6.2.4 Dec 08, 2017: Carl Zeiss Meditec grows by 9% in fiscal year 2016/17 27

6.3 Government and Public Interest 28

6.3.1 Feb 09, 2018: Deep transcranial magnetic stimulation reduces fatigue in MS patients 28

6.4 Other Significant Developments 28

6.4.1 Jan 18, 2018: Wyss Center announces collaboration with CorTec 28

6.5 Product News 29

6.5.1 Jun 05, 2018: Effects of transcranial magnetic stimulation on the brain 29

7 Appendix 31

7.1 Research Methodology 32

7.1.1 Coverage 32

7.1.2 Secondary Research 32

7.1.3 Primary Research 33

7.1.4 Market Modeling and Forecasting 34

7.1.5 Company Share Analysis 35

7.1.6 Distribution Share Analysis 36

7.1.7 Benchmarking 36

7.2 GlobalData Consulting 36

7.3 Contact Us 37

7.4 Disclaimer 37


List Of Figure

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2025 7

Figure 2: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 10

Figure 3: Neuromodulation Devices Market, Germany, Company Share (%) 2017 16


List Of Table

1.1 List of Tables

Table 1: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2020 8

Table 2: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2021-2025 9

Table 3: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2020 11

Table 4: Neuromodulation Devices Market, Germany, Volume (Units), 2021-2025 12

Table 5: Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2020 13

Table 6: Neuromodulation Devices Market, Germany, Average Price (USD ), 2021-2025 14

Table 7: Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), USD Constant, 2017 15

Table 8: Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), USD Constant, 2017 17

Table 9: Neuromodulation Devices Market Pipeline Products 20

Table 10: Total Number of Primary Research Participants, Neurology Devices Market, by Country 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Neurology Devices, Hydrocephalus shunts, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Natus Medical Incorporated, Stryker Corp, Nevro Corp, Cerenovus, Terumo Corp, LivaNova PLC , Nihon Kohden Corp, Penumbra Inc, Integra LifeSciences Corp, B. Braun Melsungen AG, Accuray Inc, Elekta AB


Companies

Medtronic Plc

Boston Scientific Corp

Nevro Corp

LivaNova PLC

Abbott Laboratories

chat_bubbleLet's Chat